Search Results - "NEW, P. Z"
-
1
Peripheral neuropathy secondary to docetaxel (Taxotere)
Published in Neurology (1996)“…Docetaxel (Taxotere), a semisynthetic analogue of the antitumor agent paclitaxel, inhibits tubulin depolymerization. Paclitaxel produces a peripheral…”
Get full text
Journal Article -
2
Fulminant radiation-induced necrosis after stereotactic radiation therapy to the posterior fossa : Case report and review of the literature
Published in Journal of neurosurgery (01-09-2001)“…The problem of radiation-induced necrosis of normal brain surrounding the target area has been a major catalyst for the development of stereotactically focused…”
Get full text
Journal Article -
3
Intramedullary spinal histoplasmosis efficacy of gadolinium enhancement
Published in Neuroradiology (01-03-1991)Get full text
Journal Article -
4
MRI of radiation induced spinal cord glioma
Published in Neuroradiology (01-07-1990)“…Radiation induced neoplasms of the spinal cord are rare lesions. This report details the MR evaluation of a patient with radiation induced astrocytoma of the…”
Get full text
Journal Article -
5
Phase II trial of chemotherapy with temozolomide in combination with topotecan for central nervous system (CNS) metastases of solid tumors
Published in Journal of clinical oncology (20-05-2010)“…Abstract only…”
Get full text
Journal Article -
6
Targeted immunotherapy for Epstein-Barr virus: Positive central nervous system lymphoma in immunosuppressed patients
Published in Journal of clinical oncology (20-05-2010)“…Abstract only…”
Get full text
Journal Article -
7
Radiographic and immunologic responses to adjuvant immunotherapy for malignant gliomas
Published in Journal of clinical oncology (20-05-2008)“…Abstract only…”
Get full text
Journal Article -
8
Evaluation of safety and tolerance of escalating doses of RSR13 administered with a fixed dose of BCNU every six weeks in patients with recurrent malignant glioma: Results of the phase I NABTT 9806 clinical trial
Published in Journal of clinical oncology (15-07-2004)“…Abstract only…”
Get full text
Journal Article -
9
Evaluation of safety and tolerance of escalating doses of RSR13 administered with a fixed dose of BCNU every six weeks in patients with recurrent malignant glioma: Results of the phase I NABTT 9806 clinical trial
Published in Journal of clinical oncology (15-07-2004)“…Abstract only…”
Get full text
Journal Article -
10
Immunotherapy
Published in Neuro-oncology (Charlottesville, Va.) (21-10-2010)Get full text
Journal Article